The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell–Specific Expression of RALDH2

Takuya Yashiro,Masaki Yamaguchi,Yumi Watanuki,Kazumi Kasakura,Chiharu Nishiyama
DOI: https://doi.org/10.4049/jimmunol.1800492
2018-11-09
The Journal of Immunology
Abstract:RALDH2 expressed in dendritic cells (DCs) plays a critical role in the development of regulatory T cells in mesenteric lymph nodes. Despite the importance of RALDH2 in intestinal immunity, little is known about the mechanism of DC-specific expression of RALDH2. In the current study, we focused on the hematopoietic cell-specific transcription factors PU.1 and IRF4 as the determinants of <i>Aldh1a2</i> gene expression. The mRNA level of <i>Aldh1a2</i>, and subsequently the enzyme activity, were decreased by knockdown of PU.1 and IRF4 in bone marrow-derived DCs (BMDCs) of BALB/c mice. Chromatin immunoprecipitation assays showed that PU.1 and IRF4 bound to the <i>Aldh1a2</i> gene ∼2 kb upstream from the transcription start site in BMDCs. A reporter assay and an EMSA revealed that the <i>Aldh1a2</i> promoter was synergistically transactivated by a heterodimer composed with PU.1 and IRF4 via the EICE motif at -1961/-1952 of the gene. The effect of small interfering RNAs for <i>Spi1</i> and <i>Irf4</i> and specific binding of PU.1 and IRF4 on the <i>Aldh1a2</i> gene were also observed in DCs freshly isolated from spleen and mesenteric lymph nodes, respectively. GM-CSF stimulation upregulated the <i>Aldh1a2</i> transcription in Flt3 ligand-generated BMDCs, in which the IRF4 expression and the PU.1 recruitment to the <i>Aldh1a2</i> promoter were enhanced. We conclude that PU.1 and IRF4 are transactivators of the <i>Aldh1a2</i> gene in vitro and ex vivo.
immunology
What problem does this paper attempt to address?